Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | renin | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | plasmepsin X | renin | 406 aa | 352 aa | 26.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | cathepsin d (lysosomal aspartyl protease) | 0.0059 | 0.0928 | 0.1305 |
Brugia malayi | hypothetical protein | 0.0051 | 0.0279 | 0.0346 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0137 | 0.7116 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0059 | 0.0928 | 0.1153 |
Mycobacterium tuberculosis | Adenosylmethionine-8-amino-7-oxononanoate aminotransferase BioA | 0.0147 | 0.7908 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0051 | 0.0279 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0149 | 0.8053 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0137 | 0.7116 | 0.7116 |
Loa Loa (eye worm) | aspartic protease BmAsp-2 | 0.0059 | 0.0928 | 0.1153 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0149 | 0.8053 | 1 |
Mycobacterium leprae | PROBABLE ADENOSYLMETHIONINE-8-AMINO-7-OXONONANOATE AMINOTRANSFERASE BIOA | 0.0147 | 0.7908 | 0.5 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0059 | 0.0928 | 0.0928 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0137 | 0.7116 | 0.8836 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0149 | 0.8053 | 1 |
Toxoplasma gondii | aspartyl protease ASP1 | 0.0059 | 0.0928 | 1 |
Mycobacterium ulcerans | adenosylmethionine-8-amino-7-oxononanoate aminotransferase | 0.0147 | 0.7908 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0137 | 0.7116 | 0.7116 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0137 | 0.7116 | 0.8836 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0051 | 0.0279 | 0.5 |
Toxoplasma gondii | aspartyl proteinase (eimepsin), putative | 0.0059 | 0.0928 | 1 |
Plasmodium vivax | aspartyl proteinase, putative | 0.0059 | 0.0928 | 1 |
Trichomonas vaginalis | acetylornithine aminotransferase, putative | 0.0147 | 0.7908 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0051 | 0.0279 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0137 | 0.7116 | 1 |
Plasmodium vivax | plasmepsin IV, putative | 0.0059 | 0.0928 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0051 | 0.0279 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.0279 | 0.0346 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.0174 | 1 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0102 | 0.4326 | 0.5371 |
Loa Loa (eye worm) | hypothetical protein | 0.0102 | 0.4326 | 0.5371 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0137 | 0.7116 | 1 |
Plasmodium falciparum | plasmepsin VI | 0.0059 | 0.0928 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0102 | 0.4326 | 0.4326 |
Mycobacterium ulcerans | hypothetical protein | 0.0147 | 0.7908 | 0.5 |
Plasmodium falciparum | plasmepsin I | 0.0059 | 0.0928 | 1 |
Echinococcus granulosus | cathepsin d lysosomal aspartyl protease | 0.0059 | 0.0928 | 0.1305 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0137 | 0.7116 | 0.7116 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0149 | 0.8053 | 1 |
Plasmodium falciparum | plasmepsin IV | 0.0059 | 0.0928 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0137 | 0.7116 | 1 |
Plasmodium falciparum | plasmepsin II | 0.0059 | 0.0928 | 1 |
Mycobacterium tuberculosis | Probable aminotransferase | 0.0147 | 0.7908 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.